Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation

This analysis describes the population pharmacokinetics (PPK) of apixaban in nonvalvular atrial fibrillation (NVAF) subjects, and quantifies the impact of intrinsic and extrinsic factors on exposure. The PPK model was developed using data from phase I–III studies. Apixaban exposure was characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Cirincione, Brenda, Kowalski, Kenneth, Nielsen, Jace, Roy, Amit, Thanneer, Neelima, Byon, Wonkyung, Boyd, Rebecca, Wang, Xiaoli, Leil, Tarek, LaCreta, Frank, Ueno, Takayo, Oishi, Masayo, Frost, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263664/
https://www.ncbi.nlm.nih.gov/pubmed/30259707
http://dx.doi.org/10.1002/psp4.12347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263664/
https://www.ncbi.nlm.nih.gov/pubmed/30259707
http://dx.doi.org/10.1002/psp4.12347

Ejemplares similares